DNTH
Dianthus Therapeutics Inc.
96.80$
-4.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +380.2% | +188.8% | +2.7% | +0.1% | +17.5% | -56.2% | +115.9% | +108.5% | +42.0% | |
| – | +384.6% | +176.8% | +3.1% | +1.1% | +19.2% | -54.6% | +116.3% | +58.3% | +45.8% | |
| – | +1,035.1% | +13.1% | +11.5% | -10.6% | +126.4% | -88.3% | +761.2% | -82.8% | +124.1% | |
| – | +1,035.1% | +176.5% | +2.2% | +2.1% | +18.9% | -57.3% | +130.1% | +58.4% | +46.9% | |
| – | – | – | – | – | – | +282.0% | -91.5% | +68.8% | -87.4% | |
| – | – | – | – | – | – | +222.7% | – | – | – | |
| – | – | – | – | – | – | +2,797.0% | – | – | – | |
| – | +80.1% | +181.6% | +74.2% | -12.8% | -2.5% | -45.2% | +11.4% | +104.4% | +74.3% | |
| – | +80.1% | +151.5% | +35.5% | -19.0% | -5.0% | -24.3% | +17.1% | +91.6% | +66.6% | |
| – | – | – | – | – | – | – | +19.1% | -23.3% | +14.7% | |
| – | -90.0% | +1,991.0% | -19.5% | +33.7% | -19.1% | -61.6% | +123.7% | +75.4% | +112.4% | |
| – | +456.5% | +189.4% | -3.1% | +1.9% | +20.0% | -57.3% | +129.3% | +108.7% | +40.0% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -5.8% | +11.1% | +18.7% | +25.1% | +9.1% | +37.5% | +546.4% | +13.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.